Biospecifics Technologies (BSTC) Tops Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts BSTC Hot Sheet
Price: $88.53 --0%
Financial Fact:
Total Cost and Expenses: 2.16M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Total Cost and Expenses: 2.16M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Biospecifics Technologies (NASDAQ: BSTC) reported Q2 EPS of $0.37, $0.02 better than the analyst estimate of $0.35. Revenue for the quarter came in at $6.2 million versus the consensus estimate of $6.25 million.
For earnings history and earnings-related data on Biospecifics Technologies (BSTC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies upgrades Five Below to Buy, sees path to TJX-like re-rating
- Bit Digital (BTBT) Misses Q2 EPS by 27c
- Burry doubles down on Nebius short after stock surges 34% on earnings
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
